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ABSTRACT 
 
Introduction: Food allergies, the second most common form of allergic disorders 
in Western countries, have been on the rise in the US over the past few decades 
especially in young children.  As the exact causes of food sensitizations are still 
unknown, much research has been dedicated to solving the mystery of how and why 
individuals develop food allergies in the first place.  However, very few studies have 
focused solely on the prevalence of food allergies in the adult population.  Furthermore, 
the prevalence of food allergies in expecting mothers and their potential impact on 
mother-baby health outcomes have barely been investigated.  As such, this retrospective 
chart review study aimed at comparing the prevalence of food allergies in pregnant 
women to that of the adult US population and investigated the potential effects of 
maternal food allergies on perinatal maternal outcomes and infant health. 
vi 
Methods: A total of 595 maternal charts and 614 infant charts were reviewed for 
expecting mothers age 18 to 49 years old who gave birth at New Hanover Regional 
Medical Center in Wilmington, NC, between November 15, 2011 and November 15, 
2012.  Mothers’ data collected included basic demographic information, presence and 
nature of food allergies, and if applicable, occurrence and length of High Risk 
Antepartum visits.  In addition to basic infant demographic information, the infant 
health outcomes collected were, when applicable: gestational age at birth, birth weight, 1 
and 5 minute APGAR scores, NICU admissions and length of stay, as well as infant 
death.  All statistical tests were two-tailed and p values < 0.05 were considered 
significant. 
Results: Food allergies were documented in 5.6% (N = 22) of the mothers, which 
was not significantly different from the national average reported by the FDA (Vierk et 
al., 2007).  The most commonly reported allergy in the study’s pregnant women sample 
was seafood (42.2%), and the least common maternal food hypersensitivity disorder in 
the sample was egg allergy (2.2%).  No significant relationship was found between the 
presence of maternal food allergies and maternal or infant health outcomes.   
Conclusion: Our study found that the proportion of pregnant women with food 
allergies was consistent with the FDA-reported percentage of US adult population 
affected by food allergies.  Furthermore, we were unable to establish significant 
relationships between the presence of maternal food allergies and mother-baby health 
outcomes. 
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INTRODUCTION 
 
 Over the past few decades, the rise in chronic diseases among Western cultures 
has changed the face of medicine and the delivery of care.  Asthma, diabetes, and 
rheumatoid arthritis are just a few examples of the chronic diseases plaguing American 
society.  While acute diseases and emergency care imply the use of drastic treatments 
and procedures, chronic diseases necessitate a different medical approach.  With 
constant symptoms and the omnipresent danger of seeing a patient’s condition 
worsening, physicians must have a keen understanding of chronic diseases’ etiology, 
pathology, and evolution.  Hence, substantial effort has been dedicated to develop the 
best treatments for persistent and life-threatening chronic diseases. 
Food allergies are chronic immune diseases that have been on the rise in the past 
decade (Ben-Shoshan, Turnbull, & Clarke, 2012a).  Although less prominent than other 
hypersensitivity diseases, food allergies have recently been coined the great “second 
wave” of allergic disorders, the first one being allergic asthma (Prescott & Allen, 2011, p. 
155).  The correlation between a mother’s food allergies and her child’s future inclination 
for similar diseases is a current hot topic in immunology research, due to the dramatic 
increase in the number of children affected by allergies.  One example of this rising 
epidemic is the doubling of peanut allergies in children under the age of five within a 
five-year period in the US (Sampson, 2004).  The data pertaining to pediatric food 
allergies and their incidence is abundant and fed by ongoing research; however, little is 
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known about the current prevalence of adult food allergies (Chaudhuri, Gonzales, 
Jesurun, Ambat, & Mandal-Chaudhuri, 2012).  In fact, the data on adult food allergy in 
the US is sparse and even contradicting at times.  What is known, however, is that major 
chronic diseases complicate virtually every aspect of pregnancy: from the difficult 
management of the chronic disease itself to increases in the risk of pre-term births 
(Sorensen et al., 2003).  With up to 30% of U.S. women in childbearing age affected by 
some allergic disease (Pali-Schöll, Motala, & Jensen-Jarolim, 2009a), it is surprising that 
little effort has been made to investigate the prevalence of food allergies in expecting 
mothers.  Specifically, “no studies have focused explicitly on the prevalence of food 
allergy in pregnant women primarily because often the immune response in the 
offspring is the main focus of research” (Pali-Schöll et al., 2009a). 
 
Specific aims 
As little data comparing the prevalence of food allergies in pregnant women to 
that of the general adult population exists, it is currently unknown whether the presence 
of food allergies in pregnant women can be associated with potential pregnancy 
complications.  Correlating the occurrence of food allergies in pregnant women to that of 
the general population could generate pertinent data, not only to optimize the care of 
allergic expecting mothers, but also to deepen the investigation of mother-infant 
interrelationship in the context of food allergies.  
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The purpose of this study is to investigate the presence of food allergies in 
pregnant women and their associated risks by: 
1) Identifying any discrepancies in the prevalence of food allergies among 
pregnant women compared to the general population in the US. 
2) Correlating the presence of maternal food allergies to antepartum maternal 
complications. 
3) Correlating the presence of maternal food allergies to the newborn infant’s 
health outcomes. 
We hypothesize that the distribution of food allergies among pregnant women 
will coincide with that of published data for the general US population, as reported by  
Vierk, Koehler, Fein, and Street in their 2007 report Prevalence of self-reported food allergy 
in American adults and use of food labels.  Additionally, we suspect that women with food 
allergies will be more likely to experience complications during pregnancy than women 
with no food allergies. We also believe that children born to mothers with existing food 
allergies at time of birth will exhibit poorer health outcomes than those born to mothers 
with no food allergies. 
By investigating the prevalence of food allergies in pregnant women we hope to 
reinforce the need for the special care and education of affected expecting mothers.  
Following the correlation of maternal food allergies’ effects with both the mother’s and 
the infant’s health outcomes, we also hope to provide some insight on the potential risks 
and complications food allergies may pose to expecting mothers and their babies. 
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BACKGROUND 
 
Etiology of food allergies 
With physiological symptoms ranging from benign skin rashes to lethal 
anaphylaxis, the immunologic background of allergies is both diverse and complex.  
While the mechanisms leading to the common allergic reactions have been investigated 
for decades and are well understood, the precise etiology of some allergies still remains 
unresolved.  The Gell and Coombs classification system separates allergic reactions into 
four distinct classes, based on the nature of the immune malfunction causing the 
misidentification of a non-threatening antigen as an offending agent.  According to 
Sampson (2004), food allergies are mostly attributable to Type I hypersensitivity 
reactions, Type IV cell-mediated hypersensitivity reactions, or a mixture of both.  While 
new theories have been proposed to explain the immunological origins of allergic 
reactions (Rajan, 2003), there is little data supporting that Type II (cytotoxic antigen), 
Type III (immune complex), or any other type of lesser-known hypersensitivity reactions 
are involved in allergic reactions to food (Sampson, 2004).  The four main classes of 
hypersensitivity reactions are listed in Table 1 below. 
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Table 1.  The Gell and Coombs hypersensitivity reaction classification.  The various 
types of hypersensitivity reactions are classified based on their immune mechanisms. A few 
examples of the physiologic effects engendered by the specific reactions are shown as well.  
Figure downloaded from Gherardi at “http://nfs.unipv.it”. 
 
 
 
 
 
As its name indicates, the contemporary classification of allergic disorders was 
developed and presented by Gell and Coombs in 1963 (Pamphilon & Scott, 2007).  While 
Gell and Coombs’ hypersensitivity classes have been widely accepted to describe the 
basis of allergic disorders, many advances have since been made in elucidating the 
underlying biomolecular and systemic mechanisms associated with allergic reactions.   
The first classification of hypersensitivity disorders is referred to as Type I 
allergy and is also known as the immediate type allergy due to its rapid onset, which 
can occur within minutes to hours following allergen exposure.  An apparent imbalance 
in the activity of the different immunoglobulin (Ig) types is thought to be the root cause 
of Type I allergies.  As the key mediators of the humoral immune system, B-
lymphocytes produce the various types of immunoglobulins, whose role is to identify 
and flag non-self, foreign, and offending agents, the antigens.  In the book Allergy 
Frontiers: Classification and Pathomechanisms, chapter authors Pali-Schöll and Jensen-
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Jarolim (2009b) explain the dynamics of Type I allergic reactions as the aberrant activity 
of IgE antibodies in response to a perceived antigen, thereby replacing the normal IgG- 
and IgM-mediated immune reaction.  In a process known as sensitization, the IgE bind 
to mast cells and basophils, thus “priming” these cells for future activation via antigen 
recognition (Austen, 2012).  Furthermore, by stabilizing the expression of the IgE 
receptors on the surface of those specific cells, the sensitization of the granulocytes sets 
the stage for a strong and rapid immune response upon re-exposure to the offending 
agent.  Food allergies can also be further classified depending on the location of the 
sensitization: class 1 food allergies are described as those initiated through 
gastrointestinal sensitization, while class 2 food allergies are defined as sensitization 
which occurred via inhaled allergens (Breiteneder & Ebner, 2000). 
Following sensitization, basophils, eosinophils, and mast cells, having expressed 
a large number of IgE receptors on their surfaces, will be strongly activated by the 
antigens specific to the IgE’s.  And so, upon re-exposure to the offending agent, an 
immune chain reaction is initiated which ultimately culminates in the very rapid 
symptoms of Type I allergic reactions.  The initial mediators of this chain reaction are 
histamine, prostaglandin, and leukotrienes (Brooks, Carroll, Butel, Morse, & Mietzneron, 
2010).  These immune signaling molecules all provoke potent and almost immediate 
physiological responses once released.  Histamine is an amino acid-derived compound 
with a variety of effects on the human physiology.  Through its main action on H1 
receptors, histamine increases capillary permeability and vasodilation, thus causing the 
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dermal redness and edema associated with allergen exposure.  Additionally, H1 receptor 
stimulation causes the production of powerful inflammatory mediators such as 
prostaglandins, as well as the recruitment of leukocytes (Morgan, Mikhail, & Murray, 
2003).   
The subsequent secretion of prostaglandins produces effects which parallel that 
of histamine; notably, Moss and Mertes (2005) point out that prostaglandins “increase 
capillary permeability and result in bronchospasm, pulmonary hypertension, and 
peripheral vasodilation” (para. 5).  In turn, the release of leukotrienes will recruit other 
immune cells and will cause extreme bronchospasm, as leukotrienes are some of the 
strongest known effectors of bronchial smooth muscle contraction (Moss & Mertes, 
2005).  Ultimately, the combination of IgE-mediated sensitization, the unwarranted 
ability of basophils, eosinophils, and mast cells to react to non-harmful antigens, and the 
release of large amounts of strong inflammatory mediators all culminate in the rapid 
and potent onset of Type I hypersensitivity reactions. 
 Whereas Type I hypersensitivity reactions mentioned above are mediated by IgE 
antibodies, Type IV hypersensitivity reactions are caused by T lymphocytes and 
macrophages (Levinson, 2012).  Still, in a fashion similar to that of Type I 
hypersensitivity reactions, Type IV reactions, also called delayed or cell-mediated 
hypersensitivity reactions, start with a sensitization process.  In cell-mediated allergic 
reactions, an allergen is identified as an antigen by a macrophage or other antigen 
presenting cells (APCs), and presented to a naïve helper T cell (Th0) via the APC’s surface 
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major histocompatibility complex II protein (MHC II).  It appears that the root of the 
biological aberration responsible for the allergic reaction occurs when the helper T 
lymphocyte fails to recognize the presented antigen as harmless.  Indeed, the T cell 
receptor (TCR) relies on specific amino acid sequences and molecular configurations to 
identify the pathogenic properties of the molecules presented by the APCs 
(Wucherpfennig, 2005).   
Several recurring biomolecular and physiochemical traits of food allergens have 
been identified, such as repetitive amino acid structure, high degree of glycation, and a 
propensity for molecular aggregation (Breiteneder & Mills, 2005).  Following the initial 
sensitization, the now activated helper T cell will proliferate and differentiate into 
memory (Th2) and effector (Th1) helper T lymphocytes (Eales, 2005).  Upon re-exposure to 
the antigen, Th2 memory cells will facilitate an adaptative reaction while Th1 helper cells 
will focus on the activation of cytotoxic or killer T lymphocytes.  Because type IV allergic 
reactions involves the activation and proliferation of various immune cells, the onset of 
the hypersensitivity symptoms can take up to days to develop, hence the name 
“delayed” hypersensitivity reaction.  Ultimately, the harmful nature of Type IV allergic 
reactions is caused by the unnecessary activation of cytotoxic T lymphocytes and other 
inflammatory cells, which culminates in the attack and destruction of tissues associated 
with the target antigen.   
 Just as the mechanisms of Type I and Type IV hypersensitivity reactions differ, 
so do their inflammatory mediators.  The key signaling molecules of delayed allergic 
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reactions are cytokines, used by activated T helper cells to promote the initiation of the 
cell-mediated immune cascade.  Cytokines are peptides or glycoproteins typically used 
as immune mediators in both the humoral and adaptative immune systems (Mescher, 
2010).  Following sensitization, activated T helper cells produce cytokines such as 
interleukin-2 (IL-2), a potent growth factor for B and T lymphocytes, tumor necrosis 
factor-α (TNF-α), and interferon-γ (INF-γ), all of which prompt the differentiation, 
proliferation, and activation of cytotoxic T lymphocytes, macrophages, and natural killer 
cells in response to allergen exposure (Eales, 2005).  While both Th1 and Th2 release 
cytokines once activated, the effector Th1 helper cells have the strongest influence on 
cytotoxic T cell mobilization and hence, on the physiologic manifestations of the allergic 
reaction.  Once activated, the cytotoxic T lymphocytes either induce apoptosis or directly 
lyse cells which present the allergenic antigen on their MHC I membrane proteins, 
causing cell death and tissue damage (Eales, 2005).  
 
Physiological manifestation of allergies 
Common physiological manifestations of allergic reactions include urticaria, 
angioedema, respiratory complications, and the most severe form of allergic reactions, 
anaphylaxis.  Urticaria, commonly known as the hives, is a cutaneous condition which is 
manifested by red, itchy, and possibly bumpy or welted skin (American College of 
Allergy, Asthma, and Immunology [acaai], 2010).  Angioedema can be thought of as the 
dermal and subdermal equivalent of urticaria.  Indeed, while the hives affect mostly the 
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outer surface of the skin with rashes and fluid-raised bumps, angioedema – as its name 
indicates – is the accumulation of fluid in the deeper tissues of the human body.  
However, due to the high occurrence of angioedema in the face and neck areas and the 
subsequent severe swelling of affected tissues, the risk for airway occlusion is much 
more prevalent in cases of angioedema than with urticaria (Rowe & Gaeta, 2011).  
Bronchospams, which are contractions of the bronchiole’s smooth muscles, cause the 
typical “wheezing” and shortness of breath that often accompanies asthma attacks and 
other allergic reactions.  Along with airway tract angioedema, bronchospasms can also 
compromise an allergic patient’s ability to breathe properly. 
The definition of anaphylaxis varies based on the sources, with some definitions 
focusing on the clinical symptoms observed, such as low blood pressure or extreme 
gastrointestinal symptoms, while others focus on the urgency of need for treatment 
(Rowe & Gaeta, 2011).  A report from the Second Symposium on the Definition and 
Management of Anaphylaxis, establishes the following simple definition: “Anaphylaxis is a 
serious allergic reaction that is rapid in onset and may cause death” (Sampson et al., 
2006, p. 374).  The understanding of anaphylaxis’ gravity and lethal potential, unlike its 
definition, is not a source of debate.  The combination of acute and rapid allergic 
symptoms observed in anaphylaxis creates extremely dangerous conditions for patients.  
In such reactions, arterial systolic blood pressure can drop below 90 mmHg within 
minutes in adults (Brown, 2005) and important respiratory compromise can lead to 
fainting, or in severe cases of angioedema, asphyxiation.  Hence, if an allergic patient is 
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exposed to an allergen and undergoes anaphylactic shock, it is imperative for caregivers 
and physicians to act quickly and with strong therapeutic measures.  Furthermore, 
biphasic anaphylactic events have been reported in which a second anaphylactic 
incident occurs several hours following the initial treatment, thus emphasizing the need 
not only for the immediate, but also sustained medical care of allergic incidents (Al-
Muhsen, Clarke, & Kagan, 2003).  It should be noted, however, that due to the rapid 
mechanics underlying this allergic reaction, anaphylaxis is mostly caused by Type I, and 
not Type IV hypersensitivity reactions. 
Food allergies can also be manifested through cardiovascular and 
gastrointestinal symptoms such as colitis, esophageal inflammation or reflux, emesis, 
nausea, diarrhea, and typically occur in conjunction with disturbances of multiple organ 
systems (Sampson, 2004).  Colitis, by definition, is the inflammation of the large intestine 
(“A.D.A.M.,” 2011); as a lay term however, colitis is used to describe nonspecific 
digestive disturbances, typically associated with pain.  When both Type I and Type IV 
hypersensitivities occur simultaneously, the patient may experience flare-ups, occurring 
over an underlying chronic disease state.  In such cases, the chronic manifestation of the 
allergy is supported by the cell-mediated allergy and its T-cell activation cycle (Pali-
Schöll & Jensen-Jarolim, 2009b).  A certain level of caution should be exerted when 
patients analyze their own gastrointestinal disturbances, as milder allergic reactions to 
foods may be mistaken for the symptoms of food intolerances instead of legitimate 
immune hypersensitivity reactions.  This misinterpretation of physiological symptoms 
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can be very risky, as food allergies have the potential to result in severe reactions such as 
anaphylaxis; and while food intolerances do carry their own risks, they typically do not 
cause fulminant onsets of life-threatening events. 
For the purpose of this dissertation, food intolerances refer to food-dependent 
disturbances affecting various physiological systems, excluding those disturbances 
caused by immune reactions (hypersensitivity reactions) and toxic aliments, but 
including those caused by structural or metabolic abnormalities (respective examples 
would include stomach ulcers and lactase deficiency) (Zopf, Baenkler, Silbermann, 
Hahn, & Raithel, 2009).  According to Zopf et al. (2009), food intolerances represent 
nearly 15% to 20% of all food-induced reactions and are mainly triggered by the 
following offending agents or pathologies: salicylates and biogenic amines, sulfites, 
sodium glutamate, colorants and preservatives, sweeteners, and enzymopathies.  Unlike 
allergies, food intolerances often develop as subsequent effects to existing diseases, such 
as the diarrhea and flatulence associated with lactase deficiency following milk 
consumption.  Difficulties exist when differentiating between food allergies and 
intolerances in the medical clinic: just like allergies, food intolerances can cause 
respiratory manifestations, such as runny or stuffy nose, and asthma (Zopf et al., 2009).  
Furthermore, it should also be noted that food intolerances and allergies may also occur 
simultaneously in a patient.  Differential diagnosis is thus critical to properly identify 
the source of the pathology presented by ailing patients.  Elevated serum levels of IgE 
may hint towards a Type I hypersensitivity reaction, although the presence of 
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hypersensitivity and exact identity of an allergen should be confirmed by an oral 
provocation test.  Differentiating a Type IV hypersensitivity reaction from food 
intolerance is more complex due to the delayed onset of the allergic symptoms (Zopf et 
al., 2009).  Lastly, it should be noted that the absence of immune reaction in food 
intolerances should not undermine the severity of the situation: an individual with 
severe food intolerances may experience more debilitating and consequential symptoms 
than those caused by a mild food allergy. 
 
Identity of food allergens 
Compared to the common hay fever, or allergic asthma, food allergies are a 
rather new group of immune reactions emerging over the past few decades, especially in 
young children, with many food allergies persisting even into adulthood (Prescott & 
Allen, 2011).  A few common aliments known to be triggers of most food allergies are 
listed in Table 2 below. 
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Table 2.  Type of food allergens and estimated percentage of the US adult population 
affected. This table highlights the most common foods causing allergic reactions, and gives an 
estimate of the total adult US population affected by them in 2004. Tree nuts include almonds, 
pecans, cashews, walnuts, pistachios, hazelnut, macadamia, Brazil nuts, and pine nuts. Table 
amended from Sampson, 2004. 
 
Food Type US Adult Population Affected 
Milk 0.3% 
Egg 0.2% 
Peanut 0.6% 
Tree nuts 0.5% 
Fish 0.45 
Shellfish 2.0% 
Overall 3.7% 
 
 
As seen in Table 2, a relatively small percentage of the adult US population is 
affected by food allergies.  Still, that seemingly unremarkable percentage of the 
population, a mere 3.4% as reported by Sampson in his 2004 Updates on Food Allergy 
report, has more than doubled from his previous 1997 estimate of 1.5% (Sampson & Ho, 
1997).  While the numbers remain small, such a drastic increase in an adult chronic 
disease should not be ignored.  The first food listed as an allergen in Table 2 is milk.  The 
generic term “milk” often refers to the commercially available homogenized and 
pasteurized cow’s milk, of which casein proteins are the major allergens (Breiteneder & 
Mills, 2005).  Cow milk protein allergies (CMPA) are mostly manifested via 
gastrointestinal symptoms such as upset stomach, diarrhea, vomiting, and intestinal 
cramps (Giovanna, Carla, Alfina, Domenico, & Elena, 2012).  While the prevalence of 
CMFA decreases as patients age, children affected by CMFA are now growing out their 
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food allergies at a slower rate than in previous decades (Food Allergy & Anaphylaxis 
Network [FAAN], 2011).  Although milk allergy in adult is quite rare, milk intolerances 
is rather common. 
Egg allergies affect 0.2% of the US adult population and are mediated by egg 
proteins, whose allergenic potential can, as with certain other allergens, be degraded by 
heating or cooking.  The typical commercial chicken egg contains several allergenic 
proteins: ovalbumin, ovotransferrin, and ovomucoid, all of which are mostly found in 
the egg white portion of the aliment (Caubet & Wang, 2011).  While ovalbumin is the 
most abundant protein in egg whites, ovomucoid has been identified as the major 
allergen in eggs (Cooke & Sampson, 1997).  Egg allergy symptoms are mostly 
manifested by gastrointestinal disturbances but can include stronger anaphylactic or 
dermal reactions as well. 
Special attention should be paid to peanut and tree nuts allergies for several 
reasons.  Despite their low prevalence in the adult population, peanut and tree nuts 
allergies have been reported to cause the highest rate of anaphylaxis-related 
hospitalization of all food allergies, which speaks volumes for the seriousness of these 
specific allergies (Al-Muhsen et al., 2003).  While most food allergies are outgrown by 
children as they age, both peanut and tree nuts allergies are more persistent and remain 
active for longer periods of time.  It is also estimated that 8% of those in allergy 
remittance will experience recurring hypersensitivity incidents, which are reported to 
increase in severity with each event (Fleischer, 2007).  Researchers have hypothesized 
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that regular consumption of low amounts of peanuts following de-sensitization to the 
allergen may help individuals maintain their tolerance.  Another particular feature of 
peanut allergies it that they are nearly always expressed as Type I, immediate 
hypersensitivity reactions, and are thus more likely to cause anaphylactic incidents than 
other food allergies (Al-Muhsen et al., 2003).  Furthermore, while most food allergens 
cause immune reactions through ingestion of the offending substance, allergic reactions 
to peanuts are also known to be induced via inspiration of peanut dust or other volatile 
elements of peanut-derived products.  Due to the high and still increasing prevalence of 
peanut allergies in very young children, much research effort has been directed at 
studying the relationship between expecting mothers’ consumption of peanuts and the 
possibility of peanut sensitization in utero or via breast milk (DesRoches, Infante-Rivard, 
L. Paradis, J. Paradis, & Haddad, 2010).  Yet, no conclusive clinical explanation can 
account for the astonishing recent increase in peanut allergies in westernized countries’ 
youth other than, perhaps, a greater rate of peanut allergy reporting. 
Seafood allergies, comprised of fish and shellfish allergies, represent a significant 
portion of the US adult population’s food allergies.  Seafood allergies are to the adult 
population what peanut allergies are to children: they are common, have aggressive 
manifestations, and cause frequent hypersensitivity incidents (Sicherer, Muñoz-Furlong, 
& Sampson, 2004).  The most prominent study conducted on seafood allergies in the 
adult US population comes from Sicherer et al. (2004).  The greatest limitation of this 
study, as in many general population allergy surveys, is the ambiguity of seafood 
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allergies self-diagnosis by the individuals being surveyed.  Nevertheless, the 
comprehensive data compiled in this study offers the first large-scale insight in the 
prevalence, distribution, management, and impact of seafood allergies in the adult US 
population.  As such, Sicherer et al. (2004, p. 163) found that “convincing and/or 
physician-diagnosed seafood allergy” is reported to occur in approximately 2.3% of the 
adult population, and that unlike the high rates of de-sensitization to peanut allergies, 
only 3% to 4% of adults affected by seafood allergies outgrow their specific fish or 
shellfish allergy.  A particular trait of seafood allergies is that unlike most food allergies, 
they often develop in adulthood as opposed to childhood: respectively, nearly 40% of 
fish and 60% of shellfish allergies are first observed in adults (Sicherer et al., 2004).  The 
most common offending biomolecular agent in fish allergies is parvalbumin, a special 
type of calcium-binding albumin protein which often triggers Type I hypersensitivity 
reactions (Breiteneder & Mills, 2005).  Despite the obvious risks associated with seafood 
allergies and the report that over half of individuals with seafood allergies experience 
“tight throat” symptoms during allergic incidents, only 8.6% of Sicherer et al.’s survey 
participants had a prescription for self-injectable epinephrine (2004).  
While Table 2 represents only a short list of the most common food allergens in 
the adult US population, virtually any aliment has the potential to be a food allergen.  
The fate of a specific food as an allergen depends on multiple factors ranging from 
molecular characteristics, such as heat resistance, amino acid sequence, or ligand-
binding capabilities, to patient-specific traits such as genetic predispositions and 
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epigenetic influences (Breiteneder & Mills, 2005).  Despite the varied identities and 
pathological mechanisms of food allergens, hypersensitivity reactions caused by food 
can be efficiently treated and resolved, if addressed in time. 
 
Diagnosis, Management and Treatment of allergic reactions 
 As previously mentioned, diagnosing food allergies can be challenging due to 
the risk implied with the consumption of the allergen, the difficulty in singling out a 
specific food, and the overlapping of intolerance and allergy symptoms.  The first steps 
in identifying the clinical presence of a food allergy are the administration of a skin prick 
test (SPT) and IgE serum analysis.  Both the SPT and serum analysis aim at detecting the 
presence of food protein-specific IgE antibodies (Sicherer, 2009).  However, while the 
presence of food-specific IgE in a person’s serum may be indicative of an existing food 
sensitization, only 30 % to 40% of patients with positive IgE results will actually 
experience clinical manifestations when consuming the suspected allergen (Sampson & 
Ho, 1997).  Serum IgE testing was found to have a sensitivity (true positive) rate of 60% 
to 95% due to the potential marking of non-IgE antibodies in the sample.  The specificity 
(true negative) rate of IgE serum testing was reported to range from 30% to 90%, which 
was curiously lower than the true negative rate of the SPT (Siles & Hsieh, 2011).  
Ultimately, the FDA does not recommend that a clinical diagnosis for food allergies be 
made uniquely on the results of IgE allergen tests (Food and Drug Administration 
[FDA], 2012).  
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 Known as the gold standard in food allergy diagnosis, double blind placebo-
controlled food challenge (DBPCFC) is used to confirm the presence of food allergies 
especially after inconclusive skin prick or serum IgE tests.  In their 2009 review on food 
allergy diagnostic testing, Eckman, Saini, and Hamilton (2009) reported a 29% to 79.5% 
sensitivity rate, and a very high specificity of 97% to 99% for DBPCFC.  Hence, while the 
rate of true positive results is variable, a negative DBPCFC result almost certainly 
exculpates certain foods from being allergens, keeping in mind that sensitization could 
still occur at a later time.  The observed variation in true positive rates could be 
explained by the fact that up to 35% of placebos can cause positive allergic reactions 
during food challenges.  Despite its stellar reputation, the DBPCFC is not without 
limitations.  Indeed, as no true standardized procedures exist for the delivery of the 
DBPCFC, results of the test may not be interchangeable between clinical practices and 
vary from test to test (Eckman et al. 2009).  Furthermore in patients prone to serious 
anaphylactic reactions, the ingestion of allergens may constitute a significant health 
hazard, outweighing the benefits of a food challenge diagnosis.  In such cases of highly 
reactive patients, strong skin prick test results have been shown to have extremely high 
specificity, thus allowing medical professionals to bypass the risk associated with food 
challenges administration by relying on SPTs (Sporik, Hill, & Hosking, 2000). 
 To date, the best treatment for food allergies is the strict avoidance of the 
offending aliment.  However, these dietary restrictions can impose great stress on 
patients’ lifestyles, which is why much research is dedicated to finding alternative 
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therapies for food allergy patients.  While immunotherapy has been applied successfully 
since the early 20th century to treat certain allergic diseases such as asthma, an array of 
studies have produced conflicting results concerning the efficacy and safety of using 
subcutaneous, sublingual, and oral immunotherapy to induce long term tolerance in 
food allergy patients (Wang & Sampson, 2010).  Novel combinations of oral 
immunotherapy and anti-IgE monoclonal antibodies have, however, shown promising 
results in recent clinical trials, prompting further investigation of this specific 
therapeutic approach (Khoriaty & Umetsu, 2013).  Other areas of food allergy therapy 
research include modified recombinant vaccine and alternative medicine remedies.  Still, 
no therapy has proven to be as effective in preventing food-induced allergic reactions as 
complete food avoidance and preventative education of patients. 
 When food allergens are consumed, the severity and rapidity of the allergic 
response, along with the preparedness of the patient and his or her entourage, 
determine the outcome of the allergic event.  For milder allergic reactions, supportive 
treatment is indicated: over the counter (OTC) corticosteroids and antihistamines such 
as H1 blockers are used to curb inflammation and can be prescribed by physicians for 
more appropriate dosage and delivery method (Rowe & Gaeta, 2011).  H1 blockers are 
known to help control symptoms of pruritus and rhinitis, and generally block the milder 
effects of food-induced hypersensitivity reactions (Skidgel & Erdös, 2011).  Acute 
allergic reactions and anaphylaxis, contrary to milder allergic reactions, must be treated 
both aggressively and rapidly.  In fact, Clark, Espinola, Rudders, Banerji, and Camargo 
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(2011) estimated that out of the approximated 200,000 yearly emergency room visits 
caused by acute allergic reactions, 90,000 – nearly half of those visits - were attributed to 
anaphylaxis.  Urgent treatment is required for patients undergoing anaphylaxis as the 
severe hypotension and respiratory compromise associated with this type of allergic 
reaction can, in rare cases, be lethal.  The first steps in treating patients with suspicion of 
anaphylaxis are, relative to the clinical evaluation of the patient, the securing of the 
airways and administration of oxygen as well as epinephrine (Rowe & Gaeta, 2011).   
Due to its multipotent properties, epinephrine is the preferred drug used to treat 
and reverse the symptoms of acute allergic and anaphylaxis reactions.  Through its 
major action as a β2 receptor agonist, epinephrine stimulates bronchodilation, while its 
simultaneous action on α1 receptors also induces vasoconstriction and reduces edema 
(Rowe & Gaeta, 2011).  Hence, epinephrine works against the physiological mechanisms 
of anaphylactic shock by restoring a higher blood pressure and stabilizing respiratory 
functions.  However, side effects of epinephrine can include arrhythmias (e.g. 
tachycardia), and other serious cardiovascular irregularities, which may explain the 
reluctance of certain physicians to readily use the drug in urgent situations, or to 
prescribe self-administered epinephrine dispenser to allergic patients (Kemp, Lockey, & 
Simons, 2008).  
 As previously stated, while anaphylaxis is a frequent cause of emergency room 
visits, its occurrence within the general US population is relatively rare. Yet, pregnant 
women and their infants are more vulnerable to the potential effects of anaphylaxis due 
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Fetus 
The fetus receives its oxygen from 
the uterine vasculature via diffusion 
through the placenta. 
to the fragile physiological balance between an expecting mother and her unborn child, 
as well as the risks associated with the drugs currently used in the treatment of 
anaphylaxis.  Anaphylaxis can be extremely damaging and even lethal to both the 
mother and the fetus; however, it is the fetus who suffers most from anaphylactic events 
(Simon & Schatz, 2012).  In order to grasp the danger of anaphylaxis to an unborn infant, 
it is important to understand the dependence of a fetus on maternal uterine blood flow, 
as illustrated in Figure 1. 
 
 
 
 
 
 
 
 
 
 
Figure 1.  Fetal oxygen supply.  In order for the fetus to obtain oxygen, the mother’s 
uterus must first receive adequate volume of oxygenated blood.  Through the uterine wall, the 
mother’s circulatory system supports the delivery of oxygen required for survival and 
development of the fetus.  
 
As seen in Figure 1, oxygen is provided to the fetus by maternal blood delivered 
to the uterus, via gas exchange through the placenta barrier.  In turn, the amount of 
blood delivered to the mother’s uterus is dependent on arterial blood pressure, as the 
Uterus 
Oxygenated blood is 
delivered to the mother’s 
uterus via the arterial system. 
Deoxygenated blood is 
returned to the mother’s heart 
via the venous system. 
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uterus does not possess vascular autoregulatory mechanisms (Chaudhuri et al., 2008).  
Low blood flow to the uterus triggers a systemic compensatory mechanism in the fetus, 
directing most of the available oxygen to vital organs such as the brain, heart, and 
placenta (Simon & Schatz, 2012).  Still, if ischemia or hypoxia, or both persist, as can be 
the case in maternal anaphylaxis, these protective measures cannot sustain adequate 
oxygenation, and severe fetal neurological damage (encephalopathy) is often noted 
postpartum.   
The current recommended treatment for pregnant women exhibiting signs of 
anaphylaxis is nearly identical to that of non-carrying individuals.  While the immediate 
therapeutic care focuses on the mother, fetal heart rate must be closely monitored 
throughout the maternal treatment of anaphylaxis, and emergency Caesarean section 
must be performed if sustained signs of fetal distress are observed, or in cases of 
refractory anaphylaxis (Simon & Schatz, 2012).  However, emergency Caesarean sections 
typically require that the carrying mother be put under general anesthesia, a situation 
which can mask certain symptoms of anaphylaxis and its relapse.  Hence special 
vigilance should be enforced if an anaphylactic mother is put under general anesthesia 
for the purpose of urgent surgical procedures (Chaudhuri et al., 2008). 
The first step in treating anaphylactic expecting mothers includes the securing of 
the respiratory tracts, which in some pregnancies, can be complicated by existing edema 
of the upper airways (Simon & Schatz, 2012).  Next, oxygen and epinephrine should be 
administered as needed for remediation of hypoxia and low blood pressure.  An 
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important feature of the anaphylaxis treatment in pregnant women is the placement of 
the mother on her left side; this specific position is strategic and aims at avoiding the 
compression of the vena cava, thereby increasing the venous return to the mother’s heart 
and supporting proper perfusion of the placenta (Simon & Schatz, 2012).  Additionally, 
difficulties can be encountered when attempting to perform resuscitation on term 
pregnant women, due to the limited range of physical manipulation possible on fully 
gravid patients. 
A debate currently exists on the appropriate use of vasopressors in the treatment 
of anaphylaxis in pregnant women.  One of epinephrine’s qualities, as previously 
mentioned, is its ability to stimulate both α and β receptors.  However, animal studies 
have shown that the stimulation of the uterus’ α receptors by sympathomimetic drugs 
can cause an increase in the uterine vascular bed resistance, subsequently decreasing 
oxygenation of the fetus (Chaudhuri et al., 2008).  Some researchers speculate that the 
secondary decrease in uterine perfusion caused by the administration of epinephrine 
actually worsens the hypoxic condition of the fetus, potentially leading to more severe 
neurological damage in the unborn infant (Chaudhuri et al., 2008).  While epinephrine is 
still considered to be the drug of choice when treating anaphylactic hypotension and 
respiratory distress, a few other agents shown in Table 3 have been suggested to reverse 
the effects of life-threatening allergic reactions. 
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Table 3.  Potential drugs for the treatment of anaphylaxis in pregnant women.  Several 
drugs are currently used, or under investigation, for the treatment of anaphylactic shock.  
However, due to the additional concern of fetus viability, each drug has its benefits and 
disadvantages when applied to the specific population of pregnant women.  Derived from 
Chaudhuri et al., 2008. 
 
Drug 
Receptors 
stimulated 
Advantages Disadvantages 
Epinephrine α and β  
 Increases blood pressure 
via vasoconstriction 
 Reduces edema 
 Induces bronchodilation 
 Can cause tachycardia 
and other arrhythmias 
 May reduce uterine 
perfusion 
Phenylephrine α  
 Restores blood pressure 
 Causes less maternal side 
effects and less fetal 
acidosis than epinephrine 
 Has not been used in the 
context of anaphylaxis in 
pregnant women 
Ephedrine β  
 Restores blood pressure 
 Causes minimal uterine 
vasoconstriction 
 Has an inotrophic effect on 
cardiac muscle 
 May not be as effective as 
epinephrine at restoring 
blood pressure 
 Has only been used in 
animal models 
 
 
 
As seen in Table 3, there is no “ideal” drug for the treatment of anaphylaxis in 
pregnant women.  The simultaneous needs for maternal vasoconstriction and fetal 
perfusion counteract each other, creating a dangerous situation for both mother and 
baby.  Despite its potential negative effects on the fetus, epinephrine remains the drug of 
choice when treating anaphylactic events, whether for a pregnant or non-pregnant 
individual.  As the lack in literature reveals, little pharmacological research has been 
dedicated to the treatment of anaphylaxis in pregnant women, due to its rare 
occurrence.  Most cases of anaphylaxis occurring during the course of a pregnancy are 
found to be caused by food, insect stings, and medication.  The majority of anaphylactic 
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events occurring during the process of labor and delivery, on the other hand, are found 
to be initiated by medical materials such as latex, or by drugs administered during the 
hospital stay itself (Simon & Schatz, 2012).  Still, as the prevalence of food allergies 
increases in western countries, a better understanding of the treatment of anaphylactic 
shock in the already vulnerable pregnant population is necessary. 
When treating milder allergic reactions, common OTC H1 blockers are 
considered relatively safe both for expecting and breastfeeding mothers (So, Bozzo, 
Inoue, & Einarson 2010).  Two respective classes of antihistamines are currently 
marketed: so-called first generation antihistamines, which are known to have a sedating 
effect, and second generation antihistamines, which lack the inconvenient drowsiness 
associated with their predecessors (Aelony, 1998).  While extensive research has been 
performed on the effects of first generation antihistamines on pregnant women and their 
unborn infants, relatively few studies have investigated these same issues with the 
second generation drugs (So et al., 2010).  Still, the use of antihistamine H1 blockers, both 
of the first and second generations, is widely accepted as safe in the treatment of allergic 
pregnant women.  In contrast, existing research on the safety of corticosteroid use to 
treat allergic pregnant women showed inconsistent results: some studies reported no 
correlation between the use of corticosteroids during the first semester of pregnancy and 
infant health outcomes, while others found an increased risk for oral clefts in children 
whose mother used corticosteroids during pregnancy (Pali-Schöll et al., 2009a).  
Ultimately, expecting mothers should avoid taking drugs at all cost during their 
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pregnancy, but sensible therapy must be used when the risks of drug administration 
outweigh the consequences of potentially dangerous conditions such as allergies. 
 
Past, present, and future of allergies in pregnant women 
 The trends are clear: an increasing number of children (and subsequently, adults) 
are plagued by allergies.  Because this increase in allergies is most dramatically observed 
in small children, the majority of the existing research has been focused on 
understanding the sensitization of the young and identifying tentative ways to prevent 
it from occurring in the first place.  However, in view of the problems brought on by the 
growing allergic population in western countries, it is in the medical community’s direct 
interest not only to focus on the prevention and treatment of allergies in children, but 
also to determine the safest and most efficient ways to treat vulnerable adult 
populations such as pregnant women and their infants.  Certain hypersensitivity 
reactions, such as allergic asthma, have already been shown to significantly impact the 
course and outcomes of pregnancies.  For example, allergic asthma in expecting mothers 
has been linked with a higher risk of preterm birth (Sorensen et al., 2003).  Additionally, 
Schatz et al. (2003) showed that the severity of a pregnant patient’s allergic asthma was 
directly related to the exacerbations of asthma-related incidents during the course of the 
pregnancy.  With such obvious warning signs of allergies’ negative impacts on 
pregnancies, more research must be conducted to establish, or disprove, any 
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relationship between the growing epidemic of food allergies and mother-baby 
outcomes. 
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METHODS 
 
Study Design 
In order to collect food allergy data in pregnant women, a retrospective chart 
review was conducted at the New Hanover Regional Medical Center (NHRMC) in 
Wilmington, NC.  The study population included pregnant women who had given birth 
at NHRMC from November 15, 2011 to November 15, 2012.   
From this base population, pregnant women ages 18 to 49 years were identified 
and sampled.  There were no exclusion criteria in the study sample.  The following data 
was collected from the mothers’ medical records: 
 Age  
 Race 
 Presence of food allergies and nature of offending agent(s), if applicable 
 Admission and discharge dates of all high risk antepartum (HRA) visits, if 
applicable 
A patient was considered to have a food allergy when causation of the allergy listed in 
their medical record was any common aliment, excluding drugs.  For those allergens 
which could be interpreted both as aliments and drugs, such as iodine, which is found in 
high concentration both in seafood and medical contrast media, the allergen was 
considered to qualify as a food allergen.  Food allergies were subsequently divided into 
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several categories, as reported in Figure 5.  The egg, milk, fruit and vegetable, as well as 
peanut and tree nuts categories are self-explanatory.  The fruit and vegetable class was 
designed to eliminate any possible ambiguity in the identity of certain vegetable 
aliments, such as tomatoes, avocadoes, or cucumbers as a fruit or a vegetable.  The 
seafood category, just as in the previous discussion, included both fish and shellfish 
products, as well as some iodine-containing products such as seaweed.  Spices, 
supplements and condiments covered a wide range of indirect foods: additives, 
flavorings, nutritional supplements, and other food items otherwise not consumed on 
their own.  The “Other” allergens included unusual, one-time entries such as chicken 
products, mold extracts, and porcine products.  Finally, gluten products included all 
products specifically containing gluten such as pasta, bread, and records exclusively 
listing “gluten” as the cause of food allergy. 
The purpose of the HRA department at NHRMC is to treat women with known 
high-risk pregnancies or severe pre-term complications.  Since pregnant women seen in 
emergency situations are typically directed first to the Triage or Labor & Delivery 
departments, the actual transfer dates from these departments to the HRA department 
were recorded as admission dates, when possible.  HRA discharge dates were 
considered either as the respective HRA stays’ discharge date, or the date at which the 
HRA patient was transferred to a different department, such as Labor and Delivery in 
case of imminent birth. 
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The records of the infants born to the sampled mothers were also identified and 
the following infant data was collected: 
 Birth weight 
 APGAR scores (1 and 5 minutes) 
 Gestational age of infant at birth 
 Number of days in Neonatal Intensive Care Unit (NICU), if applicable 
 Infant death, if applicable 
Birth weight was collected in grams, and the respective APGAR scores were recorded as 
whole numbers based on their 10-point scale.  The gestational age at birth was recorded 
in weeks, with the number of additional gestational days computed as decimal with 
respect to a seven-day week.  If the infants born to the sampled women were admitted 
to NICU, the admission date – typically the date of birth – and the discharge date were 
recorded.   Infant death was considered as the death of the expected child prior to, 
during, or immediately following birth.  The possible death of a sampled child following 
his or her initial hospital discharge was not recorded for the purpose of this study.  This 
study was approved by the NHRMC Institutional Review Board in Wilmington, NC.  
No patient consent was required due to the retrospective nature of the study. 
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Statistics 
Based on sample size analysis, it was determined that 574 maternal charts would 
need to be reviewed in order to detect an increase in maternal food allergy prevalence 
from 6.07% to 11.07% with a power of 99%, assuming an α of 0.05.  The charts of the 
infants born to these women were also reviewed for the relationships between maternal 
food allergies and infant outcomes, though the study was not powered for these events. 
Tests used included the one-proportion z-test to compare the prevalence of food 
allergies to the FDA 2001 Food Safety Survey (Vierk et al., 2007), Student’s t-test and 
Wilcoxon Rank Sum to compare numerical variables between groups, and the Χ² test of 
independence and Fisher’s exact test to compare categorical variables between groups.  
Data were analyzed with SAS 9.1 (SAS Institute, Cary NC).  All tests were two-tailed 
and p values < 0.05 were considered significant. 
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RESULTS 
 
A total of 595 maternal charts and 614 infant charts were reviewed.  The mothers 
were predominately Caucasian (64.7%, Table 4) with an average age of 28.8 years.  Food 
allergies were documented in 5.6% (N = 22) of the subjects; at least one antepartum visit 
was recorded for 11.9% of subjects. 
 
Table 4. Baseline Characteristics of study participants.  Demographic and health 
variables for the maternal and infant study subjects are shown below.  The Other/Unknown race 
category combined individuals listed as Native American, Alaska Native, Bi-racial, Other, and 
Unknown. 
Variable Mean ± Std, N (%) 
Maternal Data  
Age (years) 28.8 ± 5.6 
Race  
 Caucasian 382 (64.7) 
 African American 132 (22.2) 
 Hispanic 32 (5.4) 
 Asian 11 (1.9) 
 Other/Unknown 35 (5.9) 
Food Allergy 22 (5.6) 
At least 1 Antepartum Visit 71 (11.9) 
Antepartum Length of Stay* (days) 3.0 (0.0 – 49.0) 
  
Infant Data  
Gender  
 Male 299 (48.7) 
 Female 312 (50.8) 
 Unspecified  3 (0.5) 
Birth Weight (grams) 3170.5 ± 730.1 
Gestational Age at Birth (weeks) 38.2 ± 3.1 
APGAR 1 Min 8.0 
APGAR 5 Min 9.0 
NICU Admission 102 (16.6) 
NICU Length of Stay* (days) 11.0 (0.0 – 113.0) 
Death 8 (1.3) 
* Data reported as median (min-max) 
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Infants were equally male and female, 16.6% of whom were admitted to NICU 
(Table 4).  There were 8 (1.3%) documented infant deaths.  Infants had an average birth 
weight of 3160.9 g, a median 1 minute APGAR score of 8, and median 5 minute APGAR 
score of 9. 
Table 5 shows the frequency of specific food allergies classes in the pregnant 
group studied, in order of most to least common. 
 
Table 5.  Classification of food allergies in pregnant women.  The major classes of food 
allergies as defined by this study are listed in order of decreasing frequency.  The number of 
pregnant women affected by each class of allergy and the relative percentage of each food 
allergy within the group of affected mothers is shown as well. The definition of each food allergen 
categorization can be found in the Methods section. 
 
Class of Allergen N (%) 
Seafood 19 (42.2) 
Fruit and Vegetables 6 (13.3) 
Peanuts and tree nuts 5 (11.1) 
Spices, supplements and condiments 4 (8.9) 
Gluten Products 3 (6.7) 
Other 3 (6.7) 
Milk 2 (4.4) 
Egg 1 (2.2) 
 
 
 
As seen in Table 5, the most commonly reported allergy in the study’s pregnant 
women sample was seafood (42.2%), and the least common maternal food 
hypersensitivity disorder in the sample was egg allergy (2.2%).  The proportion of food 
allergies in this sample of pregnant women was not significantly different from the 
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national average reported by the Food and Drug Administration 2001 Food Safety 
Survey (Vierk et al., 2007), as illustrated in Figure 2 (p = 0.5772).  
 
 
Figure 2.  Comparison of food allergies prevalence in pregnant women and adult US 
populations.  The blue bar represents the proportion of pregnant women with food allergies, 
whereas the red bar represents the prevalence of US adults with food allergies.  As can be seen 
in Figure 2, a slightly lower, yet non-significant prevalence of food allergies was recorded in 
pregnant women of our study than in the general US population.  The 6.1% food allergy 
prevalence in the adult US population was drawn from the FDA publication by Vierk et al., 2007. 
 
 
Food allergies were not significantly related to having any antepartum 
admissions (p = 0.5777, Table 6), nor the length of antepartum admissions (p = 0.2509).  
Similarly, maternal food allergies had no relationship with infant birth weight (p = 
0.0968), 1 minute APGAR scores (p = 0.9941), 5 minute APGAR scores (p = 0.8869), or 
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NICU admissions (p = 1.0000).  However, maternal food allergies were significantly 
related to the length of NICU stay. 
 
Table 6.  Characteristics of mothers and infants between maternal food allergy groups. 
Maternal and Infant health outcomes, as defined for the study are separated by the presence of 
absence of food allergies.  Calculated p values are shown in the last column in order to indicate 
the presence of significant relationship between the various health outcome variables and the 
presence of maternal food allergies. Either percentages or variable ranges are given in 
parentheses. 
 
Variable Food Allergies No Allergies P values 
Maternal Data    
Age (years) 30.1 ± 6.2 28.8 ± 5.8 0.2161 
Race    
 Caucasian 14 (42.4) 371 (66.0) 0.0235 
 African American 15 (45.5) 117 (20.8)  
 Hispanic 2 (6.1) 30 (5.3)  
 Asian 0 (0.0) 11 (2.0)  
 Other/Unknown 2 (6.1) 33 (5.9)  
At least 1 Antepartum Visit 5 (15.2) 66 (11.7) 0.5777 
Antepartum Length of Stay* (days) 2.0 (0.0 – 25.0) 3.0 (0.0 – 49.0) 0.2509 
    
Infant Data    
Gender    
 Male 20 (55.6) 279 (48.3) 0.5769 
 Female 16 (44.4) 296 (51.2)  
 Unspecified  0 (0.0) 3 (0.5)  
Birth Weight (grams) 3160.9 ± 738.7 3328.5 ± 554.5 0.0968 
Gestational Age at Birth (weeks) 38.2 ± 3.1 38.8 ± 1.3 0.7425 
APGAR 1 Min* 8.0 (0.0 – 10.0) 8.5 (0.0 – 9.0) 0.9941 
APGAR 5 Min* 9.0 (0.0 – 10.0) 9.0 (0.0 – 10.0) 0.8863 
NICU Admission 6 (16.7) 96 (16.6) 0.9928 
NICU Length of Stay (days) 4.0 (0.0 – 7.0) 13.0 (0.0 – 113.0) 0.0179 
Death 1 (2.8) 7 (1.2) 0.3851 
* Data reported as median (min-max) 
 
 
As can be seen in Table 6, only two results were shown to be significant: the difference 
of prevalence of food allergies among pregnant women based on their race, as well as 
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the relationship between maternal food allergy and infant NICU length of stay. 
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DISCUSSION 
 
Maternal health outcomes 
The prevalence of food allergies in the US is not consistent across the nation.  
Mapping of food allergies can be a difficult task due to the varied onset of food 
hypersensitivities, the transient nature of the chronic diseases and tolerance 
development, as well as the clinical unreliability of allergy surveying methods.  While 
there is no comparable data for adult food allergies distribution in the US, Figure 3 
provides a representation of the irregular prevalence of US children’s food allergies. 
 
 
Figure 3.  Prevalence of pediatric food allergies in the US.  The US prevalence of food 
allergies in children is color-coded by state: the darker the shade, the higher the food allergy 
prevalence in that state.  The prevalence data was established through national online surveys.  
Limitations of such surveys are highlighted below.  Original figure from Gupta et al., 2012. 
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As seen in Figure 3, there is no clear pattern for the distribution of pediatric food 
allergies in the US.  In a similar fashion, we would expect the distribution of adult food 
allergies in the US to differ from state to state.  While no such map exists for the adult 
population, some studies suggest that development of food allergies may be influenced 
by the geographical location of patients (Ben-Shoshan et al. 2012b).  The finding that the 
prevalence of food allergies in pregnant women was not significantly different from that 
of the national adult population is reassuring.  Indeed, as an already vulnerable 
population, we had hoped that pregnant women would not be at greater risk for food 
allergy-related health complications, as stated in our hypothesis.  It can be noted, 
however, that unlike the relatively high prevalence of food allergies in the North 
Carolina pediatric population, the food allergy prevalence in our sample of pregnant 
women of was consistent with that of the adult national average.  This observation may 
be linked to the tendency of children to outgrow their food allergies as they age, along 
with potential inter-state migration of both children and adult populations. 
Our study also showed a significant difference in food allergy prevalence based 
on maternal race, as supported by the p value of 0.0235 shown in Table 6.  Upon closer 
observation, it was noted that Afro-American expecting mothers had the highest 
prevalence of food allergies within the study’s sample.  This result was consistent with 
the findings of Liu et al. (2012) that the likelihood of food sensitization was highest 
among the non-Hispanic black population.  Despite the many reports that Afro-
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American groups are more likely to develop food allergies, there is currently no 
accepted clinical explanation for this phenomenon. 
We initially hypothesized that food allergies would complicate expecting 
mothers’ pregnancies, a trend we considered observable through the affected mothers’ 
respective HRA visits and HRA lengths of stay.  Such hypothesis was supported by the 
report that food allergies are indeed some of the most common causes of anaphylaxis 
occurring prior to labor and delivery (Simon & Schatz, 2012).  Furthermore, as noted by 
Al-Ahmed, Alsowaidi, and Vadas (2008, p. 139), “the prevalence of anaphylaxis from all 
causes is rising, but food-induced anaphylaxis is causing a disproportionate increase in 
the rates of anaphylaxis”.  However, there appeared to be no such correlation between 
food allergies and pre-labor and delivery complications based on our study: there was 
no significant relationship between maternal food allergies and the number of 
antepartum admissions or length of antepartum stay.  
A plausible explanation for this observation could be that expecting mothers 
with food allergies may simply be more cautious in their choice of nutrition during 
pregnancy, therefore avoiding food allergens more carefully and diligently.  Secondly, 
the recording of HRA visits as the criteria for pre-term complications may not have been 
a precise variable.  Indeed, while some expecting mothers are admitted to the HRA 
department for pre-term complications, most expecting mothers with medical issues or 
emergencies are never admitted to the HRA department.  Instead, pregnant women 
seeking medical assistance may be seen and treated in different hospital areas such as 
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the Triage, Labor & Delivery, or Emergency departments.  Such medical interventions, 
while qualifying as a pregnancy “complications,” are not reflected in HRA visit data.   
Hence, it is fair to conclude that recording HRA admission and discharge data 
did not cover the full breadth of maternal complications occurring prior to birth.  In 
order to truly identify a relationship between food allergies and expecting mothers’ pre-
delivery health, the frequency of non-scheduled medical interventions and the nature of 
the medical issues experienced prior to birth should be recorded and analyzed alongside 
HRA data.  Confounding factors known to affect maternal health such as diabetes, 
asthma and concomitant or multiple allergies should also be considered in order to 
properly isolate the impact of food allergies on expecting mothers’ health. 
 
Infants’ health outcomes 
Based on the established newborn health complications caused by asthma, the 
major allergic disorder in the US population, we hypothesized that food allergies, with 
their increasing trend, would parallel the effects of maternal asthma on infant health 
outcomes.  In fact, Liu et al. (2010) found that individuals with physician-diagnosed 
asthma were at higher risk to also have one or more food allergies.  However, due to the 
differences in asthma and food allergies prevalence in the adult population, as well as 
the difference in disease manifestation, management, and treatments, the effects of food 
allergies on mother-baby health outcomes were not comparable to those of allergic 
asthma. 
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Our study found that there were no significant relationships between maternal 
food allergies and the following variables: infant birth weight, gestational age, 1 and 5 
minutes APGAR scores, frequency of NICU visits, and infant death.  While a meta-
analysis by Murphy et al. (2011) found that maternal asthma increased the risk for low 
birth weight, our study found that infant birth weight was not affected by maternal food 
allergies.  Strong data exist which support the negative effects of maternal allergic 
asthma on the risk of low gestational age (Sorensen et al., 2003); however, our study did 
not show any relationship between food allergies and gestational age.  Since birth 
weight and gestational age are generally closely  correlated, the observation that neither 
one was affected by maternal food allergies is consistent with their innate relationship.  
As previously noted, the study was not powered for infant outcomes, a statistical factor 
which may have led to the loss of some significant relationships between maternal food 
allergies and infant health outcomes. 
Unlike the abundant research associating allergies to birth weight and 
gestational age, only a handful of studies were found to investigate the APGAR scores of 
infants born to allergic mothers.  Specifically, the APGAR scores of infants born to 
mothers with allergic asthma were found to be lower than those of infants born to non-
asthmatic mothers (Syed, Zubairi, Zafar, & Qureshi, 2008).  Given the importance of 
APGAR scores in evaluating the overall health of a newborn child, this lack of published 
literature while surprising, could be explained by the relatively recent rise in allergic 
diseases.  Regardless, our study showed that food allergies in expecting mothers did not 
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affect the 1 and 5 minute APGAR scores of their newborn infant(s).  Evidently, the 
variables chosen by researchers when conducting perinatal research are subjective 
choices; however, due to the relatively few studies existing correlating maternal allergies 
and their infants’ non-allergic outcomes, there are no clear guidelines regarding which 
outcome variables should be included in such study. 
Just as for the previous infant outcomes, our study was unable to establish a 
relationship between maternal food allergy and frequency of NICU admission or infant 
death.  Our speculation that frequency of NICU stays and infant death were related to 
maternal food allergies was purely based on the expectation that food allergies, as a 
serious chronic disease, would negatively impact most infant outcomes.  Out of the 55 
results listed when searching the specific key phrase “maternal allergy” in the PubMed 
database, none of the returned articles investigated NICU stays or infant death in 
relation to maternal allergies.  The lack of published research on the effects of maternal 
allergies in correlation to general infant outcomes, once more, is illustrated by this 
database search. 
Our research does, however, show a surprising relationship between maternal 
food allergies and median NICU length of stay: infants born to mothers with food 
allergies tended to have a shorter median NICU length of stay than infants born to 
mothers with no food allergies.  While this finding is counterintuitive, and can neither 
be confirmed nor disproved by existing literature, a statistical explanation - as opposed 
to a clinical one - may justify the observation.  As seen in Table 6, the number of NICU 
44 
infants born to mothers with food allergies was extremely low (6 infants total).  This low 
sample size ultimately amplifies the effect of maternal food allergy on the median NICU 
length of stay, in turn creating a significant relationship (p = 0.0179) when there may, in 
fact, be none. 
In retrospect, the lack of statistically significant relationship between maternal 
food allergies and newborn health ratings could be due to the little effects of food 
allergies in comparison to other, more impactful maternal medical conditions such as 
poor nutrition, substance abuses, and multiple pregnancies (twin pregnancy for 
example).  Additionally, while some poor infant health outcomes have been suggested 
to be associated with the consumption of allergy medication such as corticosteroids 
inhalants (Pali-Schöll et al., 2009a), most food allergies are managed by simple allergen 
avoidance, a luxury not necessarily available to those patients allergic to pollen, 
dandruff, or insects bites.  Hence, it is possible that the lack of significant impact of 
maternal food allergies on newborn health is due to the overall lower consumption of 
allergy-controlling drugs in patients with food allergies compared to those affected by 
other hypersensitivity diseases.  The possibility that infant disorders related to maternal 
food allergy may manifest themselves later in the child’s life must also be considered. 
Since neonatal variables collected for the purpose of this study only included health 
outcomes at the time of birth, such late-onset disorders dependent on maternal food 
allergy would not have been exposed in our study. 
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Study Limitations 
The study’s design included inherent problems associated with most 
retrospective studies.  First, the fact that information was collected solely from medical 
records implied that the validity of the data collected depended entirely on the past 
input of medical personnel.  Such input could have been biased or even missing, 
depending on the conditions surrounding the clinical staff at the time of the patient visit.  
Furthermore, the medical records input was noticeably inconsistent, leaving it up to the 
research team to determine the true meaning of the data: gestational age was reported 
both in decimal and “week + days” format, and food allergy data rarely included the 
nature of allergic reaction (rash, wheezing, anaphylaxis, etc…).  As a retrospective study, 
our research did not include randomization or blinding; however, such research 
methods could not be applied even in prospective food allergy studies: prospective food 
allergy studies can, at best, be observational since neither randomization nor blinding 
are possible.  Moreover, due to the plethora of factors affecting mother-baby health 
during pregnancies, the unquestionable presence of confounding factors equally 
compromised the findings of this retrospective study.   
Another issue faced specifically by food allergy studies, especially by those 
which are retrospective in nature or survey-based, is the identification of true food 
allergies in the study participants.  As previously discussed, food allergies are clinically 
defined by the presence of hypersensitivity reactions.  While medical records do indicate 
the presence of allergies, there is no certainty that the allergy called out by the record is, 
46 
in fact, one of hypersensitivity origin as opposed to food intolerance.  Since both food 
hypersensitivity and intolerances can exhibit similar symptoms and the term “food 
allergy” is widely used as a lay term for specific food-induced discomforts, the accuracy 
of the medical records should be reconsidered when collecting this type of data.  
Because of the unpredictable patterns of food allergy sensitization and tolerance 
development, researchers should acknowledge that allergy-relevant medical records 
may be dynamic data, and not static or absolute information.  In order to optimize the 
collection of food allergy data for future prevalence studies, medical records would need 
to include more specific information about the declared food allergies, and possibly 
separate allergy and intolerance inputs.  For example, concise information should be 
noted on whether the food allergy was clinically diagnosed, the estimated allergy onset 
date, the specific physiological reaction observed by patients, and whether tolerance was 
ever developed or relapsed. 
When considered as a pilot for future prospective studies on the effects of 
maternal food allergies on infant health, this research proved useful in identifying the 
complications faced when dealing with food allergy data collection and study 
development.  As can be deduced from to the lack of literature on the subject, we believe 
this research was also unique in its comparison of maternal food allergies to mother-
baby outcomes.  Ultimately, we established that maternal food allergies had no 
significant clinical impact on either pre-natal maternal complication or infant health 
outcomes. 
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Conclusion 
Food allergies, while typically not life-threatening, have the potential to cause 
substantial harm to both expecting mothers and especially their unborn infants.  The aim 
of this study was to investigate the prevalence of pregnant mothers affected by food 
allergies, as well as any effect of maternal food allergies on mother-baby outcomes.  Our 
results showed that maternal food allergies occurred at similar prevalence rate in 
pregnant women as they did in the general US populations.  Furthermore, our 
investigation showed no statistically or clinically significant effects of maternal food 
allergies on either mother or infant health outcomes.   
While expecting mothers with food allergies should practice more cautious 
allergen avoidance in order to protect their unborn child, the majority of OTC drugs 
used to manage the milder effects of allergic reactions were found to be safe for the 
growing fetus.  Anaphylaxis in the pregnant mother, however, was found to often cause 
severe neurological damage to unborn infants and necessitated both rapid and strong 
intervention.  We hope that the findings of this research will help alleviate some of the 
worries associated with food allergies in pregnant women, while simultaneously 
emphasizing the need for adequate education and preparation of expecting mothers 
with food allergies, especially for those patients known to experience strong allergic 
reactions. 
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